| Tag | Content |
|---|
EnhancerAtlas ID | HS093-15778 |
Organism | Homo sapiens |
Tissue/cell | HL-60 |
Coordinate | chr19:45957240-45958100 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| IRF1 | MA0050.2 | chr19:45957840-45957861 | AAAAAAAAAAAGAAAGAAAAA | - | 6.59 | | Nr2f6(var.2) | MA0728.1 | chr19:45957623-45957638 | AAGGTCAAGAGATCA | + | 6.93 | | SP3 | MA0746.2 | chr19:45957693-45957706 | GGTGGGCGTGGTG | - | 6.48 | | SP8 | MA0747.1 | chr19:45957693-45957705 | GGTGGGCGTGGT | - | 6.32 |
|
| | Number of super-enhancer constituents: 6 | ID | Coordinate | Tissue/cell |
| SE_02108 | chr19:45957079-45957676 | Aorta | | SE_09930 | chr19:45956713-45960693 | CD14 | | SE_26771 | chr19:45956908-45957585 | Esophagus | | SE_38090 | chr19:45957862-45960688 | HUVEC | | SE_45809 | chr19:45956766-45960850 | Osteoblasts | | SE_64393 | chr19:45957052-45957737 | NHEK |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH19I045453 | chr19 | 45956370 | 45960535 |
|
Enhancer Sequence | CTGAGTCTCA CTTTCCTTCC TATACCATGG GCATGTTCCA GACCTTCTCC AGGGCCAGTT 60
GGGACTCAAT GAAGCTGCAT CTGGAACACC CCAATGGCTA CAAGGCCCAG CCGTGGTCTG 120
GTTTCAGGAA AGGTAAATGA AGGGTGAAGT TGGGACGGGA TGGAATTGAG GTTCAAATCA 180
CTCCATGGGA CTGGGAAAGT GGGAAGTGAA AGAGGGATGA AAGAGCGCAT TTGAAGCAGG 240
CAGACTGAGG GTCAGACTCC AGAAAGGACT TCCTCCTAGG ACTATTTTGG GGCTGGGAAC 300
TATAAGAAAT GAACTGTTTT GCTGGGCCTG GTGGCCTACA CCTGTAATCC CAGCACTTTG 360
GGAGGCCGAG GCAGGCAGAT CGCAAGGTCA AGAGATCAAG ATCATCCTGG TCAACCTGGT 420
GAAACCCCAT CTCTACTAAA AATACAAAAA TTAGGTGGGC GTGGTGGCGC GTGCCTGTAG 480
TCCCAGATAC TCAGGAGGCA GAGGCAGGAG AATCACTTGA ACTCGGGAGG CGGGGGTTGC 540
AGTGAGCCGA AATTGCGCCA CTGCACTCCA GCCTGGTGAC AGAGCAAGAC TCCCTCTCAA 600
AAAAAAAAAA AGAAAGAAAA ACATGAGCTG TTTGGAGAGC TGCCTGGAGG AAGAGAAACC 660
AGCCTGAGTT TCACAGGCTA GTGGAATTTG GAGGGGGGCA ATAATAGCAA TAACAATAGG 720
CCAGGCACGG TGGCTCACAC CTGTAATCCC AGCACTTTGG GAGGCCGAGA AGGGTGGATC 780
ACCTGAGGTC TGGAGTTCGA GACCAGCCTG GCCAGCATGG CAAAACCCTG TCTTTACTAA 840
AAATACAAAA AAAATTAACC 860
|
